Maravai LifeSciences to Unveil Q2 2025 Financials August 11
SAN DIEGO, July 28, 2025 – Maravai LifeSciences, Inc. (NASDAQ: MRVI), a key player in supplying reagents and services to the life sciences sector, is set to release its second quarter 2025 financial and operational results after market close on Monday, August 11, 2025. The company will follow this announcement with a conference call and webcast at 2:00 p.m. PT / 5:00 p.m. ET on the same day.
Investors interested in participating in the conference call can dial (800) 267-6316 or (203) 518-9783, referencing Conference ID MARAVAI. The proceedings will also be accessible via a live or archived webcast on the “Investors” section of Maravai’s official website at https://investors.maravai.com.
About maravai LifeSciences
Maravai LifeSciences is a prominent life sciences company dedicated to providing essential products that facilitate the advancement of drug therapies, diagnostics, and innovative vaccines. The company also supports critical research into human diseases. Through its subsidiary companies, Maravai holds leadership positions in nucleic acid synthesis and biologics safety testing, serving a global clientele of leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy organizations.
Contact Information:
Deb Hart
Maravai LifeSciences
+1 858-988-5917
ir@maravai.com
news-article-date">Released July 28, 2025
